entertainment -WSS

entertainment

author：comprehensive 2025-09-03 03:33:27 - browse：58

a liver made up by geometric shapes – biotech coverage from STAT — Adobe

LONDON — A drug in development as a weight loss treatment succeeded in a Phase 2 study in a serious liver condition, its developers said Monday, as the competition in the broader obesity medicine field pushes ahead.

The drug, survodutide, is being developed by the privately held German firm Boehringer Ingelheim and the Danish biotech Zealand Pharma. Zealand’s share price has doubled over the past year over the potential of the drug, and on Monday morning, shares jumped another 25%.

In the study, 83% of patients with a condition called MASH and who were treated with survodutide saw significant improvements in their disease compared to 18% of those who received placebo. The study met its primary endpoint of improvements in MASH after 48 weeks without the worsening of fibrosis, a scarring of the liver, the companies said. Secondary endpoints were also met, including an improvement in fibrosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： More tobacco lobbyists active in statehouses

knowledge

WSS

Cholera vaccine supply gets boost as demand surges globally

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

Health care needs a new profession: neuroimaging counseling

Biden calls for immediate release of Niger's president amid apparent coup

My superpower is killing ticks

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

entertainment

entertainment

hotspot

After affirmative action ruling, medical educators look to 'holistic review'

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

Novavax promises a turnaround & Lilly roils the obesity market

ER docs worry over extreme heat as a 'mass casualty event'

Affirmative action in medical school literally saved lives

Melinda French Gates resigns from Gates Foundation

After affirmative action ruling, medical educators look to 'holistic review'

H5N1 bird flu found in pasteurized milk: what we know

Medical leaders decry Supreme Court decision on affirmative action

Bird flu outbreak in cows is latest avian flu curveball

entertainment

What the cancer research community can learn from the Covid response

Attacks on the drug industry will lead to fewer breakthroughs

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Attacks on the drug industry will lead to fewer breakthroughs

Element Biosciences CEO lays out genome sequencing strategy

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

focus

knowledge

hotspot

focus